Summary
A summary is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
- Type
- Chapter
- Information
- Critical Care Compendium1001 Topics in Intensive Care & Acute Medicine, pp. 129 - 153Publisher: Cambridge University PressPrint publication year: 2023
References
Bibliography
Balas, MC, Weinhouse, GL, Denehy, L, et al. Interpreting and implementing the 2018 pain, agitation/sedation, delirium, immobility, and sleep disruption clinical practice guideline. Crit Care Med 2018; 46: 1464.Google Scholar
Barr, J, Fraser, GL, Puntillo, K, et al. Clinical practice guidelines for the management of pain, agitation, and delirium in adult patients in the intensive care unit. Crit Care Med 2013; 41: 263.Google Scholar
Barr, J, Pandharipande, PP, eds. Creating and implementing the 2013 ICU pain, agitation, and delirium guidelines for adult ICU patients. Crit Care Med 2013; 41: S1.Google Scholar
Bergeron, N, Dubois, MJ, Dumont, M, et al. Intensive Care Delirium Screening Checklist: evaluation of a new screening tool. Intens Care Med 2001; 27: 859.Google Scholar
Bienvenu, OJ, Neufeld, KJ, Needham, DM. Treatment of four psychiatric emergencies in the intensive care unit. Crit Care Med 2012; 40: 2662.Google Scholar
Brown, CH, Dowdy, D. Risk factors for delirium: are systemic reviews enough? Crit Care Med 2015; 43: 232.Google Scholar
Burry, LD, Cheng, W, Williamson, DR, et al. Pharmacological and non-pharmacological interventions to prevent delirium in critically ill patients: a systematic review and network meta-analysis. Intens Care Med 2021; 47: 943.CrossRefGoogle ScholarPubMed
Devlin, JW, Fong, JJ, Fraser, GL, et al. Delirium assessment in the critically ill. Intens Care Med 2007; 33: 929.CrossRefGoogle ScholarPubMed
Devlin, JW, Skrobik, Y, Gelinas, C, et al. Executive summary: clinical practice guidelines for the prevention and management of pain, agitation/sedation, delirium, immobility, and sleep disruption in adult patients in the ICU. Crit Care Med 2018; 46: 1532.Google Scholar
Dubois, M-J, Bergeron, N, Dumont, M, et al. Delirium in an intensive care unit: a study of risk factors. Intens Care Med 2001; 27: 1297.CrossRefGoogle Scholar
Ely, EW, Gautam, S, Margolin, R, et al. The impact of delirium in the intensive care unit on hospital length of stay. Intens Care Med 2001; 27: 1892.Google Scholar
Figueroa-Ramos, MI, Arroya-Novoa, CM, Lee, KA, et al. Sleep and delirium in ICU patients: a review of mechanisms and manifestations. Intens Care Med 2009; 35: 781.Google Scholar
Honarmand, K, Rafay, H, Le, J, et al. A systematic review of risk factors for sleep disruption in critically ill adults. Crit Care Med 2020; 48: 1066.Google Scholar
Jones, D, Hodgson, CL, Shehabi, Y, et al. Reducing confusion about post-cardiotomy delirium. Crit Care Resusc 2017; 19: 5.Google Scholar
Kronzer, VL, Avidan, MS. Preventing postoperative delirium: all that glisters is not gold. Lancet 2016; 388: 1854.Google Scholar
Luetz, A, Heymann, A, Radtke, FM, et al. Different assessment tools for intensive care unit delirium: which score to use? Crit Care Med 2010; 38: 409.CrossRefGoogle ScholarPubMed
Neto, AS, Nassar, AP, Cardoso, SO, et al. Delirium screening in critically ill patients: a systematic review and meta-analysis. Crit Care Med 2012; 40: 1946.Google Scholar
Ouimet, S, Kavanagh, BP, Gottfried, SB. Incidence, risk factors and consequences of ICU delirium. Crit Care Med 2007; 33: 66.Google Scholar
Pandharipande, P, Jackson, J, Ely, EW. Delirium: acute cognitive dysfunction in the critically ill. Curr Opin Crit Care 2005; 11: 360.Google ScholarPubMed
Pun, BT, Ely, EW. The importance of diagnosing and managing ICU delirium. Chest 2007; 132: 624.CrossRefGoogle ScholarPubMed
Riker, RR, Fraser, GL. Delirium – beyond the CAM-ICU. Crit Care Med 2020; 48: 134.CrossRefGoogle ScholarPubMed
Salluh, JI, Wang, H, Schneider, EB, et al. Outcome of delirium in critically ill patients: systematic review and meta-analysis. BMJ 2015: 350: h2538.Google Scholar
Shehabi, Y, Howe, BD, Bellomo, R, et al. Early sedation with dexmedetomidine in critically ill patients. N Engl J Med 2019; 380: 2506.Google Scholar
Stollings, JL, Kotfis, K, Chanques, G, et al. Delirium in critical illness: clinical manifestations, outcomes, and management. Intens Care Med 2021; 47: 1089.CrossRefGoogle ScholarPubMed
Weber, JB, Coverdale, JH, Kunik, ME. Delirium: current trends in prevention and treatment. Intern Med J 2004; 34: 115.CrossRefGoogle ScholarPubMed
Bibliography
Chong, TWH, Macpherson, H, Schaumberg, MA, et al. Dementia prevention: the time to act is now. Med J Aust 2021; 214: 302.Google Scholar
Guttman, R, Seleski, M, eds. Diagnosis, Management and Treatment of Dementia. Chicago: American Medical Association. 1999.Google Scholar
Harvey, K, Stough, C. Caution with complementaries for cognitive impairment. Aust Prescriber 2011; 34: 19.Google Scholar
LoGiudice, D. Dementia: an update to refresh your memory. Intern Med J 2002; 32: 535.CrossRefGoogle ScholarPubMed
Mayeux, R, Saunders, AM, Shea, S, et al. Utility of the apolipoprotein E genotype in the diagnosis of Alzheimer’s disease. N Engl J Med 1998; 338: 506.CrossRefGoogle ScholarPubMed
Panegyres, PK, Goldblatt, J, Walpole, I, et al. Genetic testing for Alzheimer’s disease. Med J Aust 2000; 172: 339.Google Scholar
Saunders, AM, Hulette, C, Welsh-Bohmer, KA, et al. Specificity, sensitivity, and predictive value of apolipoprotein-E genotyping for sporadic Alzheimer’s disease. Lancet 1996; 348: 90.Google Scholar
Schmaier, AH. Alzheimer disease is in part a thrombohaemorrhagic disorder. J Thromb Haemost 2016; 14: 991.Google Scholar
Bibliography
Brooks, BR, Walker, DL. Progressive multifocal leukoencephalopathy. Neurol Clin 1984; 2: 299.CrossRefGoogle ScholarPubMed
Cortese, I, Muranski, P, Enose-Akahata, Y, et al. Pembrolizumab treatment for progressive multifocal leukoencephalopathy. N Engl J Med 2019; 380: 1597.Google Scholar
Lennon, VA, Wingerchuk, DM, Kryzer, TJ, et al. A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet 2004: 364: 2106.CrossRefGoogle ScholarPubMed
Lindsey, JW. Multiple sclerosis and related disorders. In: Scientific American Medicine. Neurology. Hamilton: Dekker Medicine. 2020.Google Scholar
Tippett, DS, Fishman, PS, Panitch, HS. Relapsing transverse myelitis. Neurology 1991; 41: 703.Google Scholar
Tselis, A. Acute disseminated encephalomyelitis. Curr Treat Options Neurol 2001; 3: 537.Google Scholar
Wingerchuk, DM, Weinshenker, BG. Neuromyelitis optica. Curr Treat Options Neurol 2005; 71: 173.Google Scholar
Yamamura, T, Kleiter, I, Fujihara, K, et al. Trial of satralizumab in neuromyelitis optica spectrum disorder. N Engl J Med 2019; 381: 2114.Google Scholar
Bibliography
Bhatt, S, Gething, PW, Brady, OJ, et al. The global distribution and burden of dengue. Nature 2013; 496: 504.CrossRefGoogle ScholarPubMed
Gubler, DJ, Clark, GG. Dengue/dengue hemorrhagic fever: the emergence of a global health problem. Emerg Infect Dis 1995; 1: 2.CrossRefGoogle ScholarPubMed
Rigau-Perez, JG, Clark, GG, Gubler, DJ, et al. Dengue and dengue haemorrhagic fever. Lancet 1998; 352: 971.Google Scholar
Simmons, CP, Farrar, JJ, Nguyen, vV, et al. Dengue. New Engl J Med 2012; 366: 1423.CrossRefGoogle ScholarPubMed
Webster, DP, Farrar, J, Rowland-Jones, S. Progress towards a dengue vaccine. Lancet Infect Dis 2009; 9: 678.Google Scholar
Wilder-Smith, A. The expanding geographic range of dengue in Australia. Med J Aust 2021; 215: 171.Google Scholar
Bibliography
Aneja, S, Taylor, JS. Contact dermatitis and related disorders. In: Scientific American Medicine. Dermatology. Hamilton: Dekker Medicine. 2020.Google Scholar
Hanifin, JM. Atopic dermatitis: new therapeutic considerations. J Am Acad Dermatol 1991; 24: 1097.Google Scholar
Kalliomaki, M, Salminen, S, Poussa, T, et al. Probiotics and prevention of atopic disease: 4-year follow-up of randomized placebo-controlled trial. Lancet 2003; 361: 1869.Google Scholar
Katz, SI, Hall, RP, Lawley, TJ, et al. Dermatitis herpetiformis: the skin and the gut. Ann Intern Med 1980; 93: 857.Google Scholar
Krob, HA, Fleischer, AB, D’Agostino, R, et al. Prevalence and relevance of contact dermatitis allergens. J Am Acad Dermatol 2004; 51: 349.Google Scholar
LeBrec, H, Bachot, N, Gaspard, I, et al. Mechanisms of drug-induced allergic contact dermatitis. Cell Biol Toxicol 1999; 15: 57.CrossRefGoogle ScholarPubMed
Nicolis, GD, Helwig, EB. Exfoliative dermatitis: a clinicopathologic study of 135 cases. Arch Dermatol 1973; 108: 788.Google Scholar
Rietschel, RL, Fowler, JF, eds. Fisher’s Contact Dermatitis. 6th edition. Hamilton: BC Dekker. 2008.Google Scholar
Simpson, EI, Basco, M, Hanifin, J. A cross-sectional survey of complementary and alternative medicine in patients with atopic dermatitis. Am J Contact Dermat 2003; 14: 144.Google Scholar
Stevens, SR. Eczematous disorders, atopic dermatitis, and ichthyosis. In: Scientific American Medicine. Dermatology. Hamilton: Dekker Medicine. 2020.Google Scholar
Wollenberg, A, Kraft, S, Oppel, T, et al. Atopic dermatitis: pathogenetic mechanisms. Clin Exp Dermatol 2000; 25: 530.Google Scholar
Bibliography
Badia, M, Trujillano, J, Gasco, E, et al. Skin lesions in the ICU. Intens Care Med 1999; 25: 1271.Google Scholar
Fox, BJ, Odom, RB. Papulosquamous diseases: a review. J Am Acad Dermatol 1985; 12: 597.CrossRefGoogle ScholarPubMed
Gerull, R, Nelle, M, Schaible, T. Toxic epidermal necrolysis and Stevens-Johnson syndrome: a review. Crit Care Med 2011; 39: 1521.CrossRefGoogle ScholarPubMed
Hirschmann, JV. Antimicrobial prophylaxis in dermatology. Semin Cutan Med Surg 2000; 19: 2.CrossRefGoogle ScholarPubMed
Johnson, RA, Wolff, K, eds. Fitzpatrick’s Color Atlas and Synopsis of Clinical Dermatology. 6th edition. New York: McGraw-Hill. 2009.Google Scholar
Lebwohl, MG, ed. Dermatology. In: Scientific American Medicine. Hamilton: Dekker Medicine. 2020.Google Scholar
Peter, RU. Cutaneous manifestations in intensive care patients. Intens Care Med 1998; 24: 997.Google Scholar
Rietschel, RL, Fowler, JF, eds. Fisher’s Contact Dermatitis. 6th edition. Hamilton: BC Dekker 2008.Google Scholar
Roujeau, JC, Stern, RS. Severe adverse cutaneous reactions to drugs. N Engl J Med 1994; 10: 1272.Google Scholar
Sehgal, VN, Gangwani, OP. Fixed drug eruption: current concepts. Int J Dermatol 1987; 26: 67.Google Scholar
Wolff, K, Goldsmith, L, Katz, S, et al., eds. Fitzpatrick’s Dermatology in General Medicine. 7th edition. New York: McGraw-Hill. 2007.Google Scholar
Bibliography
Cattaneo, M, Harris, AS, Stromberg, U, et al. The effect of desmopressin on reducing blood loss in cardiac surgery – a meta-analysis of double-blind placebo-controlled trials. Thromb Haemost 1995; 74: 1064.Google Scholar
Gordon, AC, Russell, JA, Walley, KR, et al. The effects of vasopressin on acute kidney injury in septic shock. Intens Care Med 2010; 36: 83.Google Scholar
Fogel, MR, Knauer, CM, Andres, LL, et al. Continuous intravenous vasopressin in active upper gastrointestinal bleeding: a placebo-controlled trial. Ann Intern Med 1982; 96: 565.Google Scholar
Mannucci, PM. Desmopressin: a nontransfusional form of treatment for congenital and acquired bleeding disorders. Blood 1988; 72: 1449.Google Scholar
Bibliography
Baylis, PH. Posterior pituitary function in health and disease. Clin Endocrinol Metab 1983; 12: 747.Google Scholar
Singer, I, Oster, JR, Fishman, LM. The management of diabetes insipidus in adults. Arch Intern Med 1997; 157: 1293.Google Scholar
Wright, WL. Sodium and fluid management in acute brain injury. Curr Neurol Neurosci Rep 2012; 12: 466.Google Scholar
Bibliography
Dres, M, Goligher, EC, Heunks, LMA, et al. Critical illness-associated diaphragm weakness. Intens Care Med 2017; 43: 1441.Google Scholar
Markand, ON, Moorthy, SS, Mahomed, Y, et al. Postoperative phrenic nerve palsy in patients with open-heart surgery. Ann Thorac Surg 1985; 39: 68.CrossRefGoogle ScholarPubMed
Supinski, GS, Morris, PE, Dhar, S, et al. Diaphragm dysfunction in critical illness. Chest 2018; 153: 1040.CrossRefGoogle ScholarPubMed
Bibliography
Blaser, MJ, Smith, PD, Ravdin, JL, et al., eds. Infections of the Gastrointestinal Tract. 2nd edition. New York: Raven Press. 2002.Google Scholar
Cappell, M. Colonic toxicity of administered drugs and chemicals. Am J Gastroenterol 2004; 99: 1175.Google Scholar
Dionne, JC, Mbuagbaw, L, Devlin, JW, et al. Diarrhea during critical illness: a multicenter cohort study. Intens Care Med 2022; 48: 570.Google Scholar
Field, M, Rao, MC, Chang, EB. Intestinal electrolyte transport and diarrheal disease. N Engl J Med 1989; 321: 800 & 879.Google Scholar
Goldberg, MB, Paras, M. Gastrointestinal tract infections. In: Scientific American Medicine. Gastroenterology. Hamilton: Dekker Medicine. 2020.Google Scholar
Hellard, ME, Fairley, CK. Gastroenteritis in Australia: who, what, where, and how much? Aust NZ J Med 1997; 27: 147.Google Scholar
Kelly, CP, Pothoulakis, C, La Mont, JT. Clostridium difficile colitis. N Engl J Med 1994; 330: 257.Google Scholar
Linedale, EC, Andrews, JM. Diagnosis and management of irritable bowel syndrome: a guide for the generalist. Med J Aust 2017; 207: 309.Google Scholar
Lyerly, DM, Krivan, HC, Wilkins, TD. Clostridium difficile: its disease and toxins. Clin Microbiol Rev 1988; 1: 1.Google Scholar
Phillips, SF. Diarrhea: a current view of the pathophysiology. Gastroenterology 1972; 63: 495.Google Scholar
Schlager, TA, Guerrant, RL. Seven possible mechanisms for Escherichia coli diarrhea. Infect Dis Clin North Am 1988; 2: 607.Google Scholar
Slutsker, L, Ries, AA, Greene, KD, et al. Escherichia coli O157:H7 diarrhea in the United States: clinical and epidemiologic features. Ann Intern Med 1997; 126: 505.Google Scholar
Van Langenberg, DR, Gearry, RB, Wong, H-L, et al. The potential value of faecal lactoferrin as a screening test in hospitalized patients with diarrhoea. Intern Med J 2010; 40: 819.CrossRefGoogle ScholarPubMed
Wanke, CA, Guerrant, RL. Viral hepatitis and gastroenteritis transmitted by shellfish and water. Infect Dis Clin North Am 1987; 1: 649.Google Scholar
Wong, CS, Jelacic, S, Habeeb, RL, et al. The risk of the hemolytic-uremic syndrome after antibiotic treatment of Escherichia coli O157-H7 infections. N Engl J Med 2000; 342: 1930.Google Scholar
Young, GP, Bayley, N, Ward, P, et al. Antibiotic-associated colitis caused by Clostridium difficile: relapse and risk factors. Med J Aust 1986; 144: 303.Google Scholar
Bibliography
Frankel, SR, Eardley, A, Lauwers, G, et al. The ‘retinoic acid syndrome’ in acute promyelocytic leukemia. Ann Intern Med 1992; 117: 292.Google Scholar
Nicholls, MR, Terada, LS, Tuder, RM, et al. Diffuse alveolar hemorrhage with underlying pulmonary capillaritis in the retinoic acid syndrome. Am J Respir Crit Care Med 1998; 158: 1302.Google Scholar
Bibliography
Green, RJ, Ruoss, SJ, Kraft, SA, et al. Pulmonary capillaritis and alveolar hemorrhage: update on diagnosis and management. Chest 1996; 110: 1305.Google Scholar
Leatherman, JW, Davies, SF, Hoidal, JR. Alveolar hemorrhage syndromes: diffuse microvascular lung hemorrhage in immune and idiopathic disorders. Medicine 1984; 63: 343.Google Scholar
Schwarz, MI, Albert, RK. ‘Imitators’ of the ARDS: implications for diagnosis and treatment. Chest 2004; 125: 1530.CrossRefGoogle ScholarPubMed
Specks, U. Diffuse alveolar hemorrhage syndromes. Curr Opinion Rheumatol 2001; 13: 12.CrossRefGoogle ScholarPubMed
Young, KR. Diagnostic pitfalls in alveolar hemorrhage syndromes. Pulmonary Perspectives 2000; 17: 11.Google Scholar
Bibliography
Antman, EM, Wenger, TL, Butler, VP, et al. Treatment of 150 cases of life-threatening digitalis intoxication with digoxin-specific Fab antibody fragments. Circulation 1990; 81: 1744.Google Scholar
Brubacher, JR, Ravikumar, PR, Bania, T, et al. Treatment of toad venom poisoning with digoxin-specific Fab fragments. Chest 1996; 110: 1282.Google Scholar
Kelly, RA, Smith, TW. Recognition and management of digitalis toxicity. Am J Cardiol 1992; 69: 1186.Google Scholar
Smith, TW, Haber, E, Yeatman, L, et al. Reversal of advanced digoxin intoxication with Fab fragments of digoxin-specific antibodies. N Engl J Med 1976; 294: 797.Google Scholar
Taboulet, P, Baud, FJ, Bismuth, C. Clinical features and management of digitalis poisoning – rationale for immunotherapy. J Toxicol Clin Toxicol 1993; 31: 247.Google Scholar
Bibliography
Dobie, RA, Tobey, DN. Clinical features of diphtheria in the respiratory tract. JAMA 1979; 242: 2197.Google Scholar
Farizo, KM, Strebel, PM, Chen, RT, et al. Fatal respiratory disease due to Corynebacterium diphtheriae: case report and review of guidelines for management, investigation, and control. Clin Infect Dis 1993; 16: 59.Google Scholar
Galazka, AM, Robertson, SE, Oblapenko, GP. Resurgence of diphtheria. Eur J Epidemiol 1995; 11: 95.Google Scholar
Harmisch, JP, Tronca, E, Nolan, CM, et al. Diphtheria among alcoholic urban adults. Ann Intern Med 1989; 111: 71.Google Scholar
Mofred, A, Guerin, JM, Falfoul-Borsali, N, et al. Cutaneous diphtheria. Rev Med Interne 1994; 15: 515.Google Scholar
Bibliography
Bick, RL. Disseminated intravascular coagulation; a review of etiology, pathophysiology, diagnosis and management. Clin Appl Thromb Hemost 2002; 8: 1.CrossRefGoogle ScholarPubMed
Iba, T, Levy, JH, Warkentin, TE, et al. Diagnosis and management of sepsis-induced coagulopathy and disseminated intravascular coagulation. J Thromb Haemost 2019; 17: 1989.Google Scholar
Levi, M, ed.. Disseminated intravascular coagulation. Semin Thromb Hemost 2001; 27: 565.Google ScholarPubMed
Levi, M, Schultz, MJ. What do sepsis-induced coagulation test result abnormalities mean to intensivists. Intens Care Med 2017; 43: 581.Google Scholar
Levi, M, ten Cate, H. Disseminated intravascular coagulation. N Engl J Med 1999; 341: 586.Google Scholar
Rabinovich, A, Abdul-Kadir, R, Thachil, J, et al. DIC in obstetrics: Diagnostic score, highlights in management, and international registry – communication from the DIC and Women’s Health SSCs of the International Society of Thrombosis and Haemostasis. J Thromb Haemost 2019; 17: 1562.Google Scholar
Squizzato, A, Gallo, A, Levi, M, et al. Underlying disorders of disseminated intravascular coagulation: communication from the ISTH SSC subcommittees on Disseminated Intravascular Coagulation and Perioperative and Critical Care Thrombosis and Haemostasis. J Thromb Haemost 2020; 18: 2400.Google Scholar
Squizzato, A, Hunt, BJ, Kinasewitz, GT, et al. Supportive management strategies for disseminated intravascular coagulation: an international consensus. Thromb Haemost 2016; 203: 896.Google Scholar
Zeerleder, S, Hack, E, Wuillemin, WA. Disseminated intravascular coagulation in sepsis. Chest 2005; 128: 2864.Google Scholar
Bibliography
Charles, MJ, Wirjosemito, SA. Flying and diving: still a real hazard. J Hyperbaric Med 1989; 4: 23.Google Scholar
Elliot, DH, Hallenbeck, LM, Bove, AA. Acute decompression sickness. Lancet 1974; 2: 1193.Google Scholar
Emerson, GM. What you need to know about diving medicine but won’t find in a textbook. Emergency Med 2002; 14: 371.Google Scholar
Melamed, Y, Shupak, A, Bitterman, H. Medical problems associated with underwater diving. N Engl J Med 1992; 326: 30.Google Scholar
Moon, RE, Camporesi, EM, Kisslo, JA. Patent foramen ovale and decompression sickness in divers. Lancet 1989; 1: 513.Google Scholar
Tetzlaff, K, Reuter, M, Leplow, B, et al. Risk factors for pulmonary barotrauma in divers. Chest 1997; 112: 654.Google Scholar
Weathersby, PK, Survanshi, SS, Homer, LD, et al. Predicting the time of occurrence of decompression sickness. J Appl Physiol 1992; 72: 1541.Google Scholar
Weinmann, M, Tuxen, D, Scheinkestel, C, et al. Decompression illnesses. SPUMS J 1991; 21: 135.Google Scholar
Bibliography
Bierens, JJ, Modell, J, Pepe, P, et al., eds. Handbook on Drowning: Prevention, Rescue, Treatment. Berlin: Springer. 2005.Google Scholar
Edwards, ND, Timmins, AC, Randalls, B, et al. Survival in adults after cardiac arrest due to drowning. Intens Care Med 1990; 16: 336.Google Scholar
Golden, FS, Tipton, MJ, Scott, RC. Immersion, near-drowning and drowning. Br J Anaesthesia 1997; 79: 214.Google Scholar
Markarian, T, Loudou, A, Heyer, V, et al. Drowning classification: a reappraisal of clinical presentation and prognosis for severe cases. Chest 2020; 158: 596.Google Scholar
Szpilman, D, Bierens, JJLM, Handley, AJ, et al. Drowning. N Engl J Med 2012; 366: 2102.Google Scholar
Thom, O, Roberts, K, Devine, S, et al. Treatment of the lung injury of drowning: a systematic review. Crit Care 2021; 25: 253.Google Scholar
Williamson, JP, Illing, R, Gertler, P, et al. Near-drowning treated with therapeutic hypothermia. Med J Aust 2004; 181: 500.Google Scholar
Bibliography
Baldwin, JL, Speck, AL. Drug allergies. In: Scientific American Medicine. Allergy & Immunology. Hamilton: Dekker Medicine. 2020.Google Scholar
Gorevic, P. Drug allergy. In: Kaplan, AP, ed. Allergy. New York: Churchill Livingstone. 1985; p 473.Google Scholar
Katelaris, CH, Smith, WB. ‘Iodine allergy’ label is misleading. Aust Prescriber 2009; 22: 125.Google Scholar
Kolawole, H, Marshall, SD, Crilly, H, et al. Australian and New Zealand Allergy Group/Australian and New Zealand College of Anaesthetists perioperative anaphylaxis management guidelines. Anaesth Intens Care 2017; 45: 151.Google Scholar
Papadopoulos, J, Kane-Gill, S, Cooper, B, eds. Identification and prevention of common adverse drug events in the intensive care unit. Crit Care Med 2010; 36: 6 (suppl.).Google Scholar
Rosenberg, J, Pentel, P, Pond, S, et al. Hyperthermia associated with drug intoxication. Crit Care Med 1986; 14: 964.Google Scholar
Shear, NH, Knowles, S, Shapiro, L. Cutaneous adverse drug reactions. In: Scientific American Medicine. Dermatology. Hamilton: Dekker Medicine. 2020.Google Scholar
Solensky, R, Earl, HS, Gruchalla, RS, et al. Lack of penicillin resensitization in patients with a history of penicillin allergy after receiving repeated penicillin courses. Arch Intern Med 2002; 162: 822.Google Scholar
Bibliography
Chrispin, PS, Park, GR. Unexpected drug reactions and interactions in the critical care unit. Curr Opin Crit Care 1997; 3: 262.Google Scholar
Hansten, PB, Horn, JR. Drug Interactions. Philadelphia: Lippincott Williams and Wilkins. 2006.Google Scholar
Leape, LL, Brennan, TA, Laird, N, et al. The nature of adverse events in hospitalized patients: results from the Harvard Medical Practice Study II. N Engl J Med 1991; 324: 377.Google Scholar
Papadopoulos, J, Kane-Gill, S, Cooper, B, eds. Identification and prevention of common adverse drug events in the intensive care unit. Crit Care Med 2010; 36: 6 (suppl.).Google Scholar
Peck, CC, Temple, R, Collins, JM. Understanding consequences of concurrent therapies. JAMA 1993; 269: 1550.Google Scholar
Snyder, BD, Polasek, TM, Doogue, MP. Drug interactions: principles and practice. Aust Prescriber 2012; 35: 85.Google Scholar
Zarowitz, BJ. Drug-drug interactions in ICU. In: Parker, MM, Shapiro, MJ, Porembka, DT, eds. Critical Care: State of the Art, Chapter 4. Anaheim: Society of Critical Care Medicine. 1995; p 91.Google Scholar
Bibliography
Olson, KR, Benowitz, NL. Environmental and drug-induced hyperthermia: pathophysiology, recognition and management. Emerg Med Clin North Am 1984; 2: 459.Google Scholar
Bibliography
Adedoyin, A, Branch, RA. The effect of liver disease on drugs. Curr Opin Crit Care 1997; 3: 255.Google Scholar
Alapat, PM, Zimmerman, JL. Toxicology in the critical care unit. Chest 2008; 133: 1006.Google Scholar
Brunton, L, Hila-Dandan, R, Knollmann, BC, eds.-in-chief. Goodman & Gilman’s The Pharmacological Basis of Therapeutics. 13th edition. New York: McGraw-Hill. 2017.Google Scholar
Carruthers, S, Hoffman, B, Melmon, K, et al., eds. Melmon and Morrelli’s Clinical Pharmacology. 4th edition. New York: McGraw-Hill. 2000.Google Scholar
Chernow, B, ed. The Pharmacological Approach to the Critically Ill Patient. 3rd edition. Baltimore: Williams & Wilkins. 1994.Google Scholar
Chrispin, PS, Park, GR. Unexpected drug reactions and interactions in the critical care unit. Curr Opin Crit Care 1997; 3: 262.Google Scholar
Classen, D, Pestonik, S, Evans, R, et al. Adverse drug events in hospitalized patients: excess length of stay, extra costs and attributable mortality. JAMA 1997; 277: 301.Google Scholar
Crowe, AV, Griffiths, RD. Nutritional failure and drugs. Curr Opin Crit Care 1997; 3: 268.Google Scholar
Gora-Harper, ML, in conjunction with the Society of Critical Care Medicine. The Injectable Drug Reference. Princeton: Bioscientific Resources. 1998.Google Scholar
Karch, FE, Lasagna, L. Adverse drug reactions: a critical review. JAMA 1975; 234: 1236.Google Scholar
Koch-Weser, J. Definition and classification of adverse drug reactions. Drug Information Bulletin 1968; July/September: 72.Google Scholar
Lazarou, J, Pomeranz, B, Corey, P. Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. JAMA 1998; 279: 1200.Google Scholar
Ling, L, Clark, RF, Erickson, T, et al., eds. Toxicology Secrets. Philadelphia; Hanley & Belfus. 2001.Google Scholar
Naranjo, CA, Shear, NH, Lanctot, KL. Advances in the diagnosis of adverse drug reactions. J Clin Pharmacol 1992; 32: 897.Google Scholar
Nigen, S, Knowles, SR, Shear, NH. Drug eruptions: approaching the diagnosis of drug-induced skin diseases. J Drugs Dermatol 2003; 2: 278.Google Scholar
Papadopoulos, J, Kane-Gill, S, Cooper, B, eds. Identification and prevention of common adverse drug events in the intensive care unit. Crit Care Med 2010; 36: 6 (suppl.).Google Scholar
Paw, HGW, Shulman, R. Handbook of Drugs in Intensive Care. 6th edition. Cambridge: Cambridge University Press. 2019.Google Scholar
Shannon, MW, Borron, SW, Burns, MJ, eds. Haddad and Winchester’s Clinical Management of Poisoning and Drug Overdose. 4th edition. Philadelphia: WB Saunders. 2007.Google Scholar
Shear, NH, Knowles, S, Shapiro, L. Cutaneous adverse drug reactions. In: Scientific American Medicine. Dermatology. Hamilton: Dekker Medicine. 2020.Google Scholar
Susla, GM, Suffredini, AF, McAreavey, D, et al., eds. The Handbook of Critical Care Drug Delivery. 3rd edition. Baltimore: Williams & Wilkins. 2006.Google Scholar
Trujillo, MH, Guerrero, J, Fragachan, C, et al. Pharmacologic antidotes in critical care medicine: a practical guide for drug administration. Crit Care Med 1998; 26: 377.Google Scholar
Vargas, E, Terleira, A, Hernando, F, et al. Effect of adverse drug reactions on length of stay in surgical intensive care units. Crit Care Med 2003; 31: 694.Google Scholar
Bibliography
Aronoff, GR, Bennett, WM, Berns, JS, et al. eds. Drug Prescribing in Renal Failure: Dosing Guidelines for Adults and Children. 5th edition. Philadelphia: American College of Physicians. 2007.Google Scholar
Hoitsma, AJ, Wetzels, JFM, Koene, RAP. Drug-induced nephrotoxicity: aetiology, clinical features and management. Drug Safety 1991; 6: 131.Google Scholar
Olyaei, AJ, Bennett, WM. Pharmacologic approach to renal insufficiency. In: Scientific American Medicine. Nephrology. Hamilton: Dekker Medicine. 2020.Google Scholar
Papadopoulos, J, Kane-Gill, S, Cooper, B, eds. Identification and prevention of common adverse drug events in the intensive care unit. Crit Care Med 2010; 36: 6 (suppl.).Google Scholar
Weisbord, SD, Gallagher, M, Jneid, H, et al. Outcomes after angiography with sodium bicarbonate and acetylcysteine. N Engl J Med 2018; 378: 603.Google Scholar
Bibliography
Albertson, TE, Walby, WF, Derlet, RW. Stimulant-induced pulmonary toxicity. Chest 1995; 108: 1140.Google Scholar
Cooper, JA, White, DA, Matthay, RA. Drug-induced pulmonary disease. Am J Respir Dis 1986; 133: 321 & 488.Google Scholar
Foucher, P, Biour, M, Blayac, JP, et al. Drugs that may injure the respiratory system. Eur Respir J 1997; 10: 265.Google Scholar
Heffner, JE, Harley, RA, Schabel, SI. Pulmonary reactions from illicit substance abuse. Clin Chest Med 1990; 11: 151.Google Scholar
Parsons, PE. Respiratory failure as a result of drugs, overdoses, and poisonings. Clin Chest Med 1994; 15: 93.Google Scholar
Bibliography
Brodsky, MB, Pandian, V, Needham, DM. Post-extubation dysphagia: a problem needing multidisciplinary efforts. Intens Care Med 2020; 46: 93.Google Scholar
DeVault, KR. Symptoms of esophageal disease. In: Feldman, M, Friedman, L, Brandt, L, eds. Sleisenger and Fordtran’s Gastrointestinal and Liver Disease. 11th edition. Philadelphia: Elsevier. 2020.Google Scholar
Duncan, S, McAuley, DF, Walshe, M, et al. Interventions for oropharyngeal dysphagia in acute and critical care: a systematic review and meta-analysis. Intens Care Med 2020; 46: 1326.CrossRefGoogle ScholarPubMed
Macht, M, White, D, Moss, M. Swallowing dysfunction after critical illness. Chest 2014; 146: 1681.Google Scholar
Macht, M, Wimbish, T, Bodine, C, et al. ICU-acquired swallowing disorders. Crit Care Med 2013; 41: 2396.Google Scholar
Selvanderan, S, Wong, S, Holloway, R, et al. Dysphagia: clinical evaluation and management. Intern Med J 2021; 51: 1021.Google Scholar